Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders

 
 

Karyopharm Therapeutics Inc. (KPTI) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10y
Price: $7.10 Metrics
OS: 79.8 M
Market cap: $567 M -64 % ROIC
Net cash: $1.15 M $0.01 per share
EV: $565 M

 
TTM Valuation
EBITDA
EBIT ($74.3) M
EPS ($1.39)

Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15Dec-31-14
Revenues20.012.940.930.31.60.20.30.2
            Revenue growth55.0%-68.5%34.8%1790.1%942.2%-38.4%9.2%-40.8%
Cost of goods sold3.42.72.40.00.00.00.00.0
Gross profit16.610.238.530.31.60.20.30.2
            Gross margin83.0%79.0%94.1%100.0%100.0%100.0%100.0%100.0%
Selling, general and administrative143.8126.4105.448.824.9   
Research and development160.8150.8122.3161.4107.386.997.760.1
General and administrative     23.921.615.9
EBIT-98.3-171.9-189.3-179.9-130.5-110.7-119.1-75.8
            EBIT margin-491.4%-1332.2%-462.9%-593.0%-8133.2%-71903.9%-47630.4%-33120.5%
Pre-tax income-123.8-196.0-199.6-178.4-128.9-109.4-118.2-75.8
Income taxes0.30.30.00.00.10.10.00.0
            Tax rate      0.0%0.0%
Net income-124.1-196.3-199.6-178.4-129.0-109.6-118.2-75.8
            Net margin-620.4%-1521.5%-488.1%-588.1%-8036.4%-71153.9%-47272.4%-33090.4%
 
Diluted EPS($1.65)($2.72)($3.22)($3.14)($2.81)($2.92)($3.32)($2.43)
Shares outstanding (diluted)75.272.062.056.845.937.535.631.1
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy